SUMO-fusion and autoinduction-based combinatorial approach for enhanced production of bioactive human interleukin-24 in Escherichia coli
Sana Tahir,M. Mudassir Iqbal,M. Waheed Akhtar,Qingbing Wang,Tao Sun,Saima Sadaf
DOI: https://doi.org/10.1007/s00253-020-10921-4
IF: 5
2020-10-02
Applied Microbiology and Biotechnology
Abstract:High-level production of recombinant human interleukin-24 (IL-24), a multifunctional immunomodulatory cytokine, has been challenging due primarily to its aggregation as inclusion bodies in the bacterial host while persistent poor-expression in the insect/mammalian expression systems. The present study presents a robust, vector-host combination (pE-SUMO-IL24), auto-inducible medium (YNG/M9NG), and a simple purification scheme for soluble, bioactive, and cost-effective production of native-like IL-24 (nIL-24) in <i>Escherichia coli</i>. The final protein yield, following a three-step purification scheme (IMAC, SEC, dialysis), was 98 mg/L in shake-flask culture (with scale-up potential), which was several folds higher than reported earlier. In vitro cytotoxicity assays with HeLa and HCT116 cancer cell lines (performed using different concentrations of nIL-24) and the fluorescence activated cell sorting analysis (FACS) revealed a dose- and concentration-dependent increase in the population of pro-apoptotic cells with concomitant, statistically significant drop in the number of cells existent at G<sub>o</sub>/G1-, S-, and G2/M-phases (<i>P</i> < 0.002). The bioactive nIL-24, developed through this study, holds promise for use in further functional characterizations/applications.
biotechnology & applied microbiology